E2F-1 has dual roles depending on the cell cycle

International Journal of Biological Sciences

Volumn 6, Issue 2, 2010, Pages 116-128

  Sahin, Fikret ^a,b   Sladek, Todd L ^a,c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ANKARA UNIVERSITY   (Turkey)

^c NONE   (United States)

Author keywords

Cdc2; Cell cycle; Cmyc; Dhfr; E2F 1; Rb; TK

Indexed keywords

EID: 77952227676     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6.116     Document Type: Article

References (50)

1. Hallstrom TC, Nevins JR. Balancing the decision of cell proliferation and cell fate. Cell Cycle 2009,8:532-535.
2. Helin K, Harlow E, Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 1993,13:6501-6508.
3. Johnson DG, Ohtani K, Nevins JR. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 1994,8:1514-1525.
4. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000,60:3689-3695.
5. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998,12:2245-2262.
6. DeGregori J, Johnson DG. Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. Curr Mol Med 2006,6:739-748.
7. Yee AS, Reichel R, Kovesdi I, Nevins JR. Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex. Embo J 1987,6:2061-2068.
8. Muller H, Bracken AP, Vernell R, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 2001,15:267-285.
9. Ren B, Cam H, Takahashi Y, et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M check-points. Genes Dev 2002,16:245-256.
10. Weinmann AS, Yan PS, Oberley MJ, Huang TH, Farnham PJ. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 2002,16:235-244.
11. Black AR, Azizkhan-Clifford J. Regulation of E2F: a family of transcription factors involved in proliferation control. Gene 1999,237:281-302.
12. Weintraub SJ, Prater CA, Dean DC. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 1992,358:259-261.
13. Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 1995,375:812-815.
14. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 1998,8:28-35.
15. Muller H, Helin K. The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 2000, 1470: M1-12.
16. Batsche E, Lipp M, Cremisi C. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen. Oncogene 1994,9:2235-2243.
17. Jensen DE, Black AR, Swick AG, Azizkhan JC. Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J Cell Biochem 1997,67:24-31.
18. Jun D, Park HK, Nordin AA, Nagel JE, Kim YH. Characterization of the murine cdc2 gene. Mol Cells 1998,8:731-740.
19. Lam EW, Bennett JD, Watson RJ. Cell-cycle regulation of human B-myb transcription. Gene 1995,160:277-281.
20. van Ginkel PR, Hsiao KM, Schjerven H, Farnham PJ. E2F-mediated growth regulation requires transcription factor cooperation. J Biol Chem 1997,272:18367-18374.
21. Shan B, Lee WH. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 1994,14:8166-8173.
22. Shan B, Durfee T, Lee WH. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci U S A 1996,93:679-684.
23. Sladek TL, Jacobberger JW. Rapid titration of retroviral vectors encoding intracellular antigens by flow cytometry. J Virol 1990,64:3135-3138.
24. Sladek TL, Jacobberger JW. Dependence of SV40 large T-antigen cell cycle regulation on T-antigen expression levels. Oncogene 1992,7:1305-1313.
25. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 1992,70:337-350.
26. Sladek TL, Jacobberger JW. Simian virus 40 large T-antigen expression decreases the G1 and increases the G2 + M cell cycle phase durations in exponentially growing cells. J Virol 1992,66:1059-1065.
27. Landau NR, Littman DR. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J Virol 1992,66:5110-5113.
28. Jacobberger JW, Fogleman D, Lehman JM. Analysis of intra-cellular antigens by flow cytometry. Cytometry 1986,7:356-364.
29. Yang XH, Sladek TL. Novel phosphorylated forms of E2F-1 transcription factor bind to the retinoblastoma protein in cells overexpressing an E2F-1 cDNA. Biochem Biophys Res Commun 1997,232:336-339.
30. Lukas J, Petersen BO, Holm K, Bartek J, Helin K. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol 1996,16:1047-1057.
31. DeGregori J, Leone G, Ohtani K, Miron A, Nevins JR. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev 1995,9:2873-2887.
32. Wang ZM, Yang H, Livingston DM. Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts. Proc Natl Acad Sci U S A 1998,95:15583-15586.
33. Johnson DG, Cress WD, Jakoi L, Nevins JR. Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A 1994,91:12823-12827.
34. Yang XH, Sladek TL. Overexpression of the E2F-1 transcription factor gene mediates cell transformation. Gene Expr 1995,4:195-204.
35. Hurford RKJr., Cobrinik D, Lee MH, Dyson N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 1997,11:1447-1463.
36. Tao Y, Kassatly RF, Cress WD, Horowitz JM. Subunit composition determines E2F DNA-binding site specificity. Mol Cell Biol 1997,17:6994-7007.
37. Chestukhin A, Litovchick L, Rudich K, DeCaprio JA. Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism. Mol Cell Biol 2002,22:453-468.
38. Puri PL, Cimino L, Fulco M, et al. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. Cancer Res 1998,58:1325-1331.
39. Tedesco D, Lukas J, Reed SI. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev 2002,16:2946-2957.
40. Bhattacharya S, Garriga J, Calbo J, Yong T, Haines DS, Grana X. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 2003,22:2443-2451.
41. Sun A, Bagella L, Tutton S, Romano G, Giordano A. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell Biochem 2007,102:1400-1404.
42. Alvaro-Blanco J, Martinez-Gac L, Calonge E, et al. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence. Carcinogenesis 2009,30:440-448.
43. Moberg KH, Logan TJ, Tyndall WA, Hall DJ. Three distinct elements within the murine c-myc promoter are required for transcription. Oncogene 1992,7:411-421.
44. Campanero MR, Armstrong M, Flemington E. Distinct cellular factors regulate the c-myb promoter through its E2F element. Mol Cell Biol 1999,19:8442-8450.
45. Liu N, Lucibello FC, Zwicker J, Engeland K, Muller R. Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element. Nucleic Acids Res 1996,24:2905-2910.
46. Lam EW, Watson RJ. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. Embo J 1993,12:2705-2713.
47. Lanker S, Valdivieso MH, Wittenberg C. Rapid degradation of the G1 cyclin Cln2 induced by CDK-dependent phosphorylation. Science 1996,271:1597-1601.
48. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ. Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 2000,20:5797-5807.
49. Stengel KR, Thangavel C, Solomon DA, Angus SP, Zheng Y, Knudsen ES. RB/p107/130 pocket proteins: Protein dynamics and interactions with target gene promoters. J Biol Chem 2009. 284: 19265-19271
50. Udvadia AJ, Templeton DJ, Horowitz JM. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci U S A 1995,92:3953-3957.